Jump to the main content block

Department of Biomedical Sciences

 

 

 
:::

許勝傑(Sheng-Chieh Hsu)

Sheng-Chieh Hsu

Position

Assisant Professor

Education

Ph. D., Institute of Microbiology and Immunology, National Yang-Ming University, Taiwan

E-mail

schsu@mail.cgu.edu.tw

Office Tel

+886-3-211-8800 ext.3690

Fax

+886-3-211-8700

Laboratory

分子細胞與腫瘤研究室

Spciality

Molecular and cellular biology, Cancer biology

Lab & Research Interest

   My laboratory is interested in understanding the molecular mechanisms and functionalities of membrane proteins involved in cancer development. Specifically, my main research focuses on the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase (RTK). Overexpression or activation of EGFR is often found in tumors with epithelial origin that is also associated with poor prognosis, metastasis and chemoresistance. Interestingly, this cell membrane receptor, which has been extensively studied, not only transduces signals from the cell membrane, but also can translocate into the nucleus and play a role in gene regulation. We are currently using molecular biology, bioinformatics and pharmacological methods to explore the mechanisms and functions of membrane proteins nuclear translocation in attempt to identify new cancer biomarkers and develop treatment strategies.

Publications

Publications:

  1. Wu JC, Hsu SC, Wang SY, Huang YH, Sheen IJ, Shih HH, Syu WJ. "Defective" mutations of hepatitis D viruses in chronic hepatitis D patients. World J Gastroenterol. 11(11):1658-62, 2005.
  2. Lo HW, Hsu SC, Ali-Seyed M., Gunduz M, Xia W, Wei Y, Bartholomeusz G., Shih JY, Hung MC. Nuclear interaction of EGFR and STAT3 in the activation of iNOS/NO pathway. Cancer Cell 7(6):575-89, 2005. (SCI)
  3. Chuang CH, Chiu HJ, Hsu SC, Ho JY, Syu WJ. Comparison of Tir from enterohemorrahgic and enteropathogenic Escherichia coli strains: two homologues with distinct intracellular properties. J. Biomed. Sci. 1:73-87, 2006. (SCI)
  4. Lo HW, Hsu SC, Hung MC. EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res. Treat. 95(3):211-8, 2006. Review (SCI)
  5. Lo HW, Ali-Seyed M, Wu Y, Bartholomeusz G, Hsu SC, Hung MC. Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. J. Cell. Biochem. 98(6):1570-83, 2006. (SCI)
  6. Hsu SC and Hung MC. Characterization of a novel tripartite nuclear localization sequence in the EGFR family. J Biol. Chem. 282(14):10432-40, 2007. (SCI)
  7. Lo WH, Hsu SC, Xia W, Cao X, Shih JY, Abbruzzese JL, Hortobagyi GN, Hung MC. Epidermal growth factor receptor cooperates with signal transducer and activator 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 67(19): 9066-76, 2007. (SCI)
  8. Hsu SC, Miller SA, Wang Y, Hung MC. Nuclear EGFR is required for cisplatin resistance and DNA repair. Am. J. Transl. Res. 1(3):249-58, 2009.
  9. Huo L, Wang YN, Xia W, Hsu SC, Lai CC, Li LY, Chang WC, Wang Y, Hsu MC, Yu YL, Huang TH, Ding Q, Chen CH, Tsai CH, Hung MC. RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus. Proc. Natl. Acad. Sci. 107(37):16125-30, 2010. (SCI)